Propafenone-associated Gross Hematuria: A Case Report and Review of the Literature

Clin Ther. 2019 Aug;41(8):1614-1620. doi: 10.1016/j.clinthera.2019.05.002. Epub 2019 Jun 1.

Abstract

Purpose: Propafenone hydrochloride has been widely used for the treatment of supraventricular and ventricular arrhythmias. We present a case report of an 81-year-old patient with propafenone-associated gross hematuria.

Methods: The Naranjo Adverse Drug Reaction Probability Scale was used to assess causality. We also performed a literature search to find publications that report propafenone-associated gross hematuria.

Findings: The Naranjo scale generated a score of 6, suggesting a probable association between gross hematuria and propafenone therapy. Thirteen publications that reported an association between gross hematuria and propafenone administration were found.

Implications: A probable association exists between gross hematuria and propafenone.

Keywords: antiarrhythmic medication; gross hematuria; paroxysmal atrial fibrillation; propafenone.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged, 80 and over
  • Anti-Arrhythmia Agents / adverse effects*
  • Atrial Fibrillation / drug therapy
  • Hematuria / chemically induced*
  • Humans
  • Male
  • Propafenone / adverse effects*

Substances

  • Anti-Arrhythmia Agents
  • Propafenone